Twice-yearly subcutaneous injections significantly reduced exacerbations in hard-to-treat patients.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-approves-add-depemokimab-severe-asthma-2025a1000zt4?src=rss
Author :
Publish date : 2025-12-19 11:29:00
Copyright for syndicated content belongs to the linked Source.